GSK Says "Unique" Collaboration With Singapore Academics Aimed Squarely At Drug Discovery
This article was originally published in PharmAsia News
Executive Summary
SINGAPORE - GlaxoSmithKline said four new drug research collaborations between Singapore-based academics and GSK's global drug discovery network are "unique" alliances for the firm, pairing seasoned researchers from GSK's global network with promising academic work to bring new drugs to the market